Advanced Therapeutic Strategies and Resistance Mechanisms in CLL

ReachMD CME
14/08/2025

Listen "Advanced Therapeutic Strategies and Resistance Mechanisms in CLL "

Descargar episodio Ver en sitio original

Episode Synopsis

CME credits: 0.25
Valid until: 14-12-2025
Claim your CME credit at https://reachmd.com/programs/cme/advanced-therapeutic-strategies-and-resistance-mechanisms-in-cll/36332/



Listen to Dr. Shankara Paneesha and discover the evolving treatment landscape for relapsed CLL. Get insights on BTK resistance, new treatment options including cellular therapy, and the importance of patient-specific factors in treatment decisions.=

More episodes of the podcast ReachMD CME

Understanding Endocrine Resistance in HR+/HER2- mBC 07/10/2025
PI3K Pathway Inhibition in HR+/HER2- mBC: Mechanistic Insights 07/10/2025
Comprehensive Biomarker Testing in mBC Informs Clinical Decision Making 07/10/2025
Double Take: Pivotal Data Evaluating PI3K Inhibitor/Endocrine Therapy Regimens in mBC 07/10/2025
Triple Threat: Key Data on Simultaneous Estrogen, CDK4/6, and PI3K Inhibition in mBC 07/10/2025
Case in Point: Applying PI3K Combinations in Early Recurrent HR+/HER2- mBC 07/10/2025
PI3K Pathway Inhibitors: Safety and Tolerability Profiles 07/10/2025
The Future of PI3K Inhibition in HR+/HER2- Breast Cancer 07/10/2025
FSGS: When Solutions Fall Short 19/09/2025
Current FSGS Treatment Landscape: More Questions Than Answers 19/09/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA